Arkolith/Insider Trading/ARQT/Form 4

Matsuda Masaru

See RemarksArcutis Biotherapeutics, Inc. (ARQT) · full profile →Form 4 · filed May 6, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$192K
Net Open-Market Flow
-$192K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 4, 2026Sell(S)7K$23.27$172K128K
May 4, 2026Sell(S)884$23.61$21K127K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001798679-26-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML